P. Jacobson

发表

Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencing

W. Guan, Baolin Wu, A. Israni, 2018, The Pharmacogenomics Journal.

Pharmacogenomics of Medications Commonly Used in the Intensive Care Unit

R. S. Huang, D. Skaar, P. Jacobson, 2018, Front. Pharmacol..

Pharmacokinetics of Clofarabine in Patients With High‐Risk Inherited Metabolic Disorders Undergoing Brain‐Sparing Hematopoietic Cell Transplantation

J. Tolar, P. Orchard, Jiayin Huang, 2011, Journal of clinical pharmacology.

Donor polymorphisms of toll‐like receptor 4 associated with graft failure in liver transplant recipients

W. Guan, A. Israni, D. Schladt, 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

The impact of donor and recipient common clinical and genetic variation on estimated glomerular filtration rate in a European renal transplant population

Graham M Lord, W. Guan, A. Israni, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Personalized fludarabine dosing to reduce nonrelapse mortality in hematopoietic stem-cell transplant recipients receiving reduced intensity conditioning.

J. Wagner, M. Kirstein, D. Weisdorf, 2016, Translational research : the journal of laboratory and clinical medicine.

Precision Dosing for Tacrolimus Using Genotypes and Clinical Factors in Kidney Transplant Recipients of European Ancestry

W. Guan, Baolin Wu, A. Israni, 2021, Journal of clinical pharmacology.

Dosing equation for tacrolimus using genetic variants and clinical factors.

A. Israni, A. Birnbaum, W. Oetting, 2011, British journal of clinical pharmacology.

Design and Implementation of the International Genetics and Translational Research in Transplantation Network

Graham M Lord, Jason H. Moore, W. Guan, 2015, Transplantation.

Population Pharmacokinetics of Unbound Mycophenolic Acid in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

J. Tolar, P. Orchard, P. Jacobson, 2012, Journal of clinical pharmacology.

Undergoing Allogeneic Hematopoietic Cell Transplantation Population Pharmacokinetics of Unbound Mycophenolic Acid in Pediatric and Young Adult Patients

J. Tolar, P. Orchard, P. Jacobson, 2012 .

Higher Mycophenolate Dose Requirements in Children Undergoing Hematopoietic Cell Transplant (HCT)

J. Tolar, P. Orchard, P. Jacobson, 2008, Journal of clinical pharmacology.

Prediction of Unbound Mycophenolic Acid Concentrations in Patients After Hematopoietic Cell Transplantation

Jiayin Huang, P. Jacobson, R. Brundage, 2007, Therapeutic drug monitoring.

Mycophenolate Mofetil in Islet Cell Transplant: Variable Pharmacokinetics but Good Correlation Between Total and Unbound Concentrations

B. Hering, P. Jacobson, K. Green, 2005, Journal of clinical pharmacology.

Comparative Evaluation of Median Versus Youden Index Dichotomization Methods: Exposure–Response Analysis of Mycophenolic Acid and Acyl-Glucuronide Metabolite

A. Israni, P. Jacobson, R. Brundage, 2019, European Journal of Drug Metabolism and Pharmacokinetics.

Evidence That Established Lung Cancer Mortality Disparities in American Indians Are Not Due to Lung Cancer Genetic Testing and Targeted Therapy Disparities.

C. Aliferis, Ping Yang, R. Kratzke, 2019, Clinical lung cancer.

Impact of Obesity on Voriconazole Pharmacokinetics among Pediatric Hematopoietic Cell Transplant Recipients

M. Kirstein, J. Fisher, P. Jacobson, 2020, Antimicrobial Agents and Chemotherapy.

The Impact of Transplant Recipient and Donor Organ Type 2 Diabetes Polygenic Risk Scores on the Development of Early Post-Transplant Diabetes

W. Guan, A. Israni, K. Olthoff, 2021 .

Reply to "genetic determinants of mycophenolate-related anemia and leukopenia after transplantation"

W. Guan, A. Israni, B. Julian, 2012 .

Population pharmacokinetics of unbound mycophenolic acid in adult allogeneic haematopoietic cell transplantation: effect of pharmacogenetic factors

D. Verotta, P. Jacobson, A. Frymoyer, 2013 .

Generalizable Architectures and Principles of Informatics for Scalable Personalized and Precision Medicine (PPM) Decision Support

Steven G. Johnson, Constantin F. Aliferis, Pamala A. Jacobson, 2019, Health Informatics.

Lower Calcineurin Inhibitor Doses in Older Compared to Younger Kidney Transplant Recipients Yield Similar Troughs

A. Israni, D. Schladt, A. Matas, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Reduced Enterohepatic Recirculation of Mycophenolate and Lower Blood Concentrations are Associated with the Stool Bacterial Microbiome After Hematopoietic Cell Transplantation.

A. Khoruts, C. Staley, M. MacMillan, 2022, Transplantation and cellular therapy.

Urinary microbiome associated with chronic allograft dysfunction in kidney transplant recipients

Gabriel A. Al-Ghalith, Baolin Wu, A. Israni, 2018, Clinical transplantation.

Perceptions of pharmacogenetic exceptionalism and the implications for clinical management within an electronic health record

D. Stenehjem, P. Jacobson, Jacob T Brown, 2022, Clinical and translational science.

Finding the Dose for Hydroxychloroquine Prophylaxis for COVID‐19: The Desperate Search for Effectiveness

D. Boulware, A. Matas, R. Kandaswamy, 2020, Clinical pharmacology and therapeutics.

Exposure–response relationships for oxaliplatin-treated colon cancer cells

M. Kirstein, T. Tuttle, P. Jacobson, 2008, Anti-cancer drugs.

Telomere Length of Recipients and Living Kidney Donors and Chronic Graft Dysfunction in Kidney Transplants

W. Guan, A. Israni, D. Schladt, 2014, Transplantation.

Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.

J. Fay, B. Storer, J. Wingard, 2009, Blood.

Highly Variable Mycophenolate Mofetil Bioavailability Following Nonmyeloablative Hematopoietic Cell Transplantation

D. Weisdorf, P. Jacobson, T. DeFor, 2007, Journal of clinical pharmacology.

Treatment and Prophylaxis of Cytomegalovirus Disease

P. Jacobson, M. L. Levinson, 1992, Pharmacotherapy.

Genetic Determinants of Mycophenolate-Related Anemia and Leukopenia After Transplantation

A. Israni, B. Julian, D. Schladt, 2011, Transplantation.

Novel Polymorphisms Associated With Tacrolimus Trough Concentrations: Results From a Multicenter Kidney Transplant Consortium

A. Israni, B. Julian, D. Schladt, 2011, Transplantation.

Public Attitudes toward Pharmacogenomic Testing and Establishing a Statewide Pharmacogenomics Database in the State of Minnesota

J. Bishop, P. Jacobson, David B Gregornik, 2022, Journal of personalized medicine.

Knowledge and attitudes of incoming pharmacy students toward pharmacogenomics and survey reliability.

W. Oetting, P. Jacobson, Y. Wen, 2022, Pharmacogenomics.

A cost-effectiveness analysis of pretreatment DPYD and UGT1A1 screening in patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI+bevacizumab (FOLFIRI+Bev).

K. Kuntz, E. Lou, D. Stenehjem, 2020 .

Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast cancer treatment

D. Yee, D. Duprez, D. Potter, 2015, SpringerPlus.

Development and Validation of the Minnesota Assessment of Pharmacogenomic Literacy (MAPL)

A. Pittenger, J. Bishop, P. Jacobson, 2022, Journal of personalized medicine.

Comparison of Dose Adjustment Strategies for Obesity in High-dose Cyclophosphamide Among Adult Hematopoietic Cell Transplantation Recipients: Pharmacokinetic Analysis.

M. Kirstein, V. Bachanova, P. Jacobson, 2022, Transplantation and cellular therapy.

Koda-Kimble and Young's applied therapeutics: The clinical use of drugs

M. Ernst, B. Alldredge, P. Jacobson, 2012 .

Predictive Value of C‐Reactive Protein and Albumin for Temporal Within‐Individual Pharmacokinetic Variability of Voriconazole in Pediatric Patients Undergoing Hematopoietic Cell Transplantation

M. Kirstein, J. Fisher, P. Jacobson, 2021, Journal of clinical pharmacology.

Stability of itraconazole in an extemporaneously compounded oral liquid.

P. Jacobson, C. Johnson, J. T. Walters, 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Rifampin–sirolimus–voriconazole interaction in a hematopoietic cell transplant recipient

P. Jacobson, Justin A Wasko, James S Westholder, 2017, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Tacrolimus trough and dose intra‐patient variability and CYP3A5 genotype: Effects on acute rejection and graft failure in European American and African American kidney transplant recipients

W. Guan, Baolin Wu, A. Israni, 2018, Clinical transplantation.

Solid‐Organ Transplantation in Older Adults: Current Status and Future Research

J. C. Frank, J. Halter, N. Powe, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Glutathione S‐Transferase A1 Genetic Variants Reduce Busulfan Clearance in Children Undergoing Hematopoietic Cell Transplantation

Xinjing Wang, J. Ross, P. Orchard, 2008, Journal of clinical pharmacology.

Donor and recipient polygenic risk scores influence the risk of post-transplant diabetes

W. Guan, A. Israni, K. Olthoff, 2022, Nature Medicine.

Quantitative high-performance liquid chromatography-electrospray ionization tandem mass spectrometry analysis of bis-N7-guanine DNA-DNA cross-links in white blood cells of cancer patients receiving cyclophosphamide therapy.

Bei Nie, P. Jacobson, Bhaskar Malayappan, 2010, Analytical chemistry.

Precision medicine, agriculture, and genome editing: science and ethics

Kavita M. Berger, C. Steer, P. Jacobson, 2019, Annals of the New York Academy of Sciences.

Concept and design of a genome-wide association genotyping array tailored for transplantation-specific studies

Marylyn D. Ritchie, Shefali S. Verma, Kelly A. Birdwell, 2015, Genome Medicine.

Inflammation in the setting of chronic allograft dysfunction post‐kidney transplant: phenotype and genotype

W. Guan, A. Israni, D. Schladt, 2013, Clinical transplantation.

Genetic and Clinical Determinants of Early, Acute Calcineurin Inhibitor-Related Nephrotoxicity: Results From a Kidney Transplant Consortium

A. Israni, A. Matas, W. Oetting, 2012, Transplantation.

Single-Nucleotide Polymorphisms, Acute Rejection, and Severity of Tubulitis in Kidney Transplantation, Accounting for Center-to-Center Variation

W. Guan, Jinbo Chen, A. Israni, 2010, Transplantation.

Fecal β-glucuronidase activity differs between hematopoietic cell and kidney transplantation and a possible mechanism for disparate dose requirements

A. Israni, A. Khoruts, C. Staley, 2022, Gut microbes.

Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network.

Juan Wu, D. Weisdorf, B. Logan, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Mycophenolic Acid and Its Metabolites in Kidney Transplant Recipients: A Semimechanistic Enterohepatic Circulation Model to Improve Estimating Exposure

A. Israni, P. Jacobson, R. Brundage, 2018, Journal of clinical pharmacology.

Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantation

D. Weisdorf, R. Remmel, P. Jacobson, 2005, Clinical pharmacology and therapeutics.

A Limited Sampling Model for Estimation of Total and Unbound Mycophenolic Acid (MPA) Area Under the Curve (AUC) in Hematopoietic Cell Transplantation (HCT)

D. Weisdorf, P. Jacobson, J. Ng, 2006, Therapeutic drug monitoring.

Drug Interactions in Organ Transplantation

P. Jacobson, K. Hardinger, W. Simmons, 2014 .

CRISPR/Cas9 Genetic Modification of CYP3A5 *3 in HuH-7 Human Hepatocyte Cell Line Leads to Cell Lines with Increased Midazolam and Tacrolimus Metabolism

W. Guan, A. Israni, E. Schuetz, 2017, Drug Metabolism and Disposition.

Concepts of Genomics in Kidney Transplantation

A. Israni, A. Matas, W. Oetting, 2017, Current Transplantation Reports.

Genomewide Association Study of Tacrolimus Concentrations in African American Kidney Transplant Recipients Identifies Multiple CYP3A5 Alleles

W. Guan, P. Kwok, A. Israni, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients.

W. Guan, Baolin Wu, A. Israni, 2018, Pharmacogenomics.

Obesity effects on cyclophosphamide-induced DNA damage in hematopoietic cell transplant recipients.

N. Tretyakova, P. Jacobson, L. Johnson, 2012, In vivo.

Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-versus-Host Disease in Reduced-Intensity Conditioning Double Umbilical Cord Blood Transplantation.

J. Wagner, M. MacMillan, D. Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pharmacogenomics of COVID-19 therapies

P. Jacobson, M. Nicol, Takuto Takahashi, 2020, npj Genomic Medicine.

Posttransplant day significantly influences pharmacokinetics of cyclosporine after hematopoietic stem cell transplantation.

P. Jacobson, R. Brundage, J. Ng, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Formation of cyclophosphamide specific DNA adducts in hematological diseases

N. Tretyakova, J. Wagner, M. MacMillan, 2012, Pediatric blood & cancer.

Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors

K. Klotz, M. Kirstein, S. Kachler, 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

Isradipine Therapy in Hypertensive Pediatric Patients

P. Jacobson, Cary E. Johnson, Min H. Song, 1997, The Annals of pharmacotherapy.

Genetic Variants Associated with Immunosuppressant Pharmacokinetics and Adverse Effects in the DeKAF Genomics Genome Wide Association Studies.

W. Guan, Baolin Wu, A. Israni, 2019, Transplantation.

High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2010, Bone Marrow Transplantation.

Gentamicin and Tobramycin Pharmacokinetics in Pediatric Bone Marrow Transplant Patients

R. Hutchinson, P. Jacobson, P. Jacobson, 1997, The Annals of pharmacotherapy.

CYP2C19 Phenotype and Body Weight-Guided Voriconazole Initial Dose in Infants and Children after Hematopoietic Cell Transplantation

M. Kirstein, J. Fisher, P. Jacobson, 2021, Antimicrobial agents and chemotherapy.

Analysis of 75 Candidate SNPs Associated with Acute Rejection in Kidney Transplant Recipients: Validation of rs2910164 in MicroRNA MIR146A.

W. Guan, Baolin Wu, A. Israni, 2019, Transplantation.

Genetics of acute rejection after kidney transplantation

A. Israni, W. Oetting, C. Dorr, 2018, Transplant international : official journal of the European Society for Organ Transplantation.

Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantation

J. Wagner, P. Jacobson, T. DeFor, 2009, Bone Marrow Transplantation.

Tacrolimus troughs and genetic determinants of metabolism in kidney transplant recipients: A comparison of four ancestry groups

W. Guan, Baolin Wu, A. Israni, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Validation of tacrolimus equation to predict troughs using genetic and clinical factors.

W. Guan, A. Israni, A. Birnbaum, 2012, Pharmacogenomics.

Pharmacogenomics education, research and clinical implementation in the state of Minnesota.

C. Aliferis, R. S. Huang, B. Ness, 2021, Pharmacogenomics.

Pharmacogenetic effect of the UGT polymorphisms on mycophenolate is modified by calcineurin inhibitors

A. Matas, W. Oetting, S. Basu, 2008, European Journal of Clinical Pharmacology.

Stability of isradipine in an extemporaneously compounded oral liquid.

P. Jacobson, C. Johnson, J. L. MacDonald, 1994, American journal of hospital pharmacy.

Weight‐based mycophenolate mofetil dosing predicts acute GVHD and relapse after allogeneic hematopoietic cell transplantation

J. Wagner, M. MacMillan, D. Weisdorf, 2018 .

Multigene predictors of tacrolimus exposure in kidney transplant recipients.

W. Guan, A. Israni, A. Matas, 2015, Pharmacogenomics.

Genome-wide association study identifies the common variants in CYP3A4 and CYP3A5 responsible for variation in tacrolimus trough concentration in Caucasian kidney transplant recipients

A. Israni, W. Oetting, R. Remmel, 2017, The Pharmacogenomics Journal.

Validation of single nucleotide polymorphisms associated with acute rejection in kidney transplant recipients using a large multi‐center cohort

W. Guan, A. Israni, D. Schladt, 2011, Transplant international : official journal of the European Society for Organ Transplantation.

Differentially Expressed Gene Transcripts Using RNA Sequencing from the Blood of Immunosuppressed Kidney Allograft Recipients

W. Guan, Baolin Wu, S. Scherer, 2015, PloS one.

Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health System

P. Mróz, J. Bishop, H. Dunnenberger, 2021, Frontiers in Genetics.

Exploring Potential for a Personalized Medicine Approach to Smoking Cessation With an American Indian Tribe

D. Hatsukami, R. Tyndale, C. Dorr, 2022, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Stability of tacrolimus in an extemporaneously compounded oral liquid.

J. Foster, P. Jacobson, N. West, 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

NPHP1 (Nephrocystin-1) Gene Deletions Cause Adult-Onset ESRD.

A. Israni, H. Snieder, B. van der Zwaag, 2018, Journal of the American Society of Nephrology : JASN.

Influence of Kidney Transplant Status on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage

N. Limdi, T. Beasley, B. Julian, 2017, Pharmacotherapy.

Tacrolimus trough levels after month 3 as a predictor of acute rejection following kidney transplantation: a lesson learned from DeKAF Genomics

W. Guan, A. Israni, D. Schladt, 2013, Transplant international : official journal of the European Society for Organ Transplantation.

Early detection of SARS‐CoV‐2 and other infections in solid organ transplant recipients and household members using wearable devices

Ryan A. Kellogg, R. Redfield, M. Snyder, 2021, Transplant international : official journal of the European Society for Organ Transplantation.

Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factor.

J. Wagner, Chi Chen, G. Vercellotti, 2020, Blood advances.

Pharmacokinetic-pharmacodynamic modelling of acute N-terminal pro B-type natriuretic peptide after doxorubicin infusion in breast cancer.

M. Kirstein, A. Blaes, P. Jacobson, 2016, British journal of clinical pharmacology.

Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencing

W. Guan, Baolin Wu, A. Israni, 2018, The Pharmacogenomics Journal.

Fludarabine Pharmacokinetics in Nonmyeloablative Hematopoietic Cell Transplantation (HCT): Association with Engraftment and Neurotoxicty.

J. Wagner, Jeffrey S. Miller, D. Weisdorf, 2005 .

Opportunities for Personalizing Colorectal Cancer Care: An Analysis of SEER-Medicare Data

K. Kuntz, J. Farley, P. Jacobson, 2022, The Pharmacogenomics Journal.

Tacrolimus Elimination in Four Patients With a CYP3A5*3/*3 CYP3A4*22/*22 Genotype Combination

W. Guan, Baolin Wu, A. Israni, 2018, Pharmacotherapy.

Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizers

W. Guan, Baolin Wu, A. Israni, 2022, Clinical transplantation.

Validation Is Critical for Genome‐Wide Association Study–Based Associations

A. Israni, W. Oetting, P. Jacobson, 2017, American Journal of Transplantation.

Pharmacogenomics of COVID-19 therapies.

P. Jacobson, M. Nicol, Takuto Takahashi, 2020, NPJ genomic medicine.

Pharmacogenomics in kidney transplant recipients and potential for integration into practice

W. Guan, Baolin Wu, A. Israni, 2020, Journal of clinical pharmacy and therapeutics.

Stability of fluconazole and amino acids in parenteral nutrient solutions.

P. Jacobson, C. Johnson, P. Couch, 1992, American journal of hospital pharmacy.

CYP51A1 polymorphism and voriconazole-associated hepatotoxicity in children undergoing hematopoietic cell transplant

M. Kirstein, J. Fisher, P. Jacobson, 2021, International journal of clinical pharmacology and therapeutics.

Cytochrome P450 isozymes 3A4 and 2B6 are involved in the in vitro human metabolism of thiotepa to TEPA

A. Birnbaum, R. Remmel, P. Jacobson, 2002, Cancer Chemotherapy and Pharmacology.

Sterility of Filgrastim (G-CSF) in Syringes

P. Jacobson, C. Pierson, V. Spadoni, 1996, The Annals of pharmacotherapy.

Genotype-guided tacrolimus dosing in African American kidney transplant recipients

W. Guan, D. Schladt, A. Matas, 2015, The Pharmacogenomics Journal.

A Multi-Marker Test for Analyzing Paired Genetic Data in Transplantation

W. Guan, Jinbo Chen, A. Israni, 2021, Frontiers in Genetics.

Addressing disparities in pharmacogenomics through rural and underserved workforce education

P. Jacobson, M. Speedie, Jacob T Brown, 2023, Frontiers in Genetics.

Glutathione S‐Transferase A1 Genetic Variants Reduce Busulfan Clearance in Children Undergoing Hematopoietic Cell Transplantation

Xinjing Wang, J. Ross, P. Orchard, 2008, Journal of clinical pharmacology.

Validation of tacrolimus equation to predict troughs using genetic and clinical factors.

W. Guan, A. Israni, A. Birnbaum, 2012, Pharmacogenomics (London).

Multigene predictors of tacrolimus exposure in kidney transplant recipients.

W. Guan, A. Israni, A. Matas, 2015, Pharmacogenomics.

Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors

K. Klotz, M. Kirstein, S. Kachler, 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

Pharmacokinetics of Clofarabine in Patients With High‐Risk Inherited Metabolic Disorders Undergoing Brain‐Sparing Hematopoietic Cell Transplantation

J. Tolar, P. Orchard, Jiayin Huang, 2011, Journal of clinical pharmacology.

Oral busulfan pharmacokinetics and engraftment in children with Hurler syndrome and other inherited metabolic storage diseases undergoing hematopoietic cell transplantation

Michael J. Thrall, W. Krivit, P. Jacobson, 2001, Bone Marrow Transplantation.

Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.

M. MacMillan, D. Weisdorf, B. Blazar, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparative Evaluation of Median Versus Youden Index Dichotomization Methods: Exposure–Response Analysis of Mycophenolic Acid and Acyl-Glucuronide Metabolite

A. Israni, P. Jacobson, R. Brundage, 2019, European Journal of Drug Metabolism and Pharmacokinetics.

Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network.

J. Bolaños-Meade, Juan Wu, D. Weisdorf, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Influence of Renal Function on Phosphoramide Mustard Exposure: A Nonlinear Mixed‐Effects Analysis

M. Kirstein, P. Jacobson, R. Brundage, 2022, Journal of clinical pharmacology.

Effects of cyclophosphamide related genetic variants on clinical outcomes of adult hematopoietic cell transplant patients

V. Bachanova, P. Jacobson, Takuto Takahashi, 2022, Cancer Chemotherapy and Pharmacology.

Higher Fludarabine and Cyclophosphamide Exposures Lead to Worse Outcomes in Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Adult Hematologic Malignancy

D. Weisdorf, V. Bachanova, P. Jacobson, 2021 .

Higher Fludarabine and Cyclophosphamide Exposures Lead to Worse Outcomes in Reduced Intensity Hematopoietic Cell Transplant for Adult Hematologic Malignancy.

D. Weisdorf, V. Bachanova, P. Jacobson, 2021, Transplantation and cellular therapy.

Stability of ganciclovir sodium and amino acids in parenteral nutrient solutions.

P. Jacobson, C. Johnson, E. Chan, 1994, American journal of hospital pharmacy.

Compatibility of cyclosporine with fat emulsion.

P. Jacobson, R. Whitmore, C. Maksym, 1993, American journal of hospital pharmacy.